XML 58 R44.htm IDEA: XBRL DOCUMENT v3.19.1
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Narrative) - USD ($)
12 Months Ended
Dec. 31, 2018
Dec. 31, 2017
Nov. 10, 2017
Jan. 08, 2016
Federal deposit insurance corporation insured limit $ 250,000 $ 250,000    
Amount in excess of FDIC limit $ 245,988 0    
Ownership interest       50.00%
Valuation allowance percentage 100.00%      
Accumulated deficit $ (29,269,000) (18,868,599)    
Working capital deficit (7,000,000)      
Research and development expense 1,408,595 1,427,341    
Advertising costs 0 13,062    
Joint venture contributions 5,000      
Allowance for doubtful accounts 7,500 0    
Deferred revenue 383,275 361,462    
Non-controlling interest 16,412 $ 46,884    
Minimum [Member]        
Capital required to sustain in operations 4,000,000      
Capital to be raised through issuance of common stock 8,000,000      
Maximum [Member]        
Capital to be raised through issuance of common stock $ 10,000,000      
Oak Therapeutics [Member]        
Ownership interest     63.00%  
Shares received     269,000